SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

79,310.01 2,008.61
( 2.60%)

Global Indices

Nasdaq

53,347.89 1,540.17
(2.97%)

Dow Jones

7,717.41 127.49
(1.68%)

Hang Seng

60,935.13 -1,253.50
(-2.02%)

Nikkei 225

10,852.07 213.64
(2.01%)

Forex

USD-INR

94.73 -0.07
(-0.07%)

EUR-INR

105.99 -0.12
(-0.11%)

GBP-INR

127.06 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

40.04

965.76

EPS(TTM)

Face Value()

Div & Yield %

20.47

0.06

Back

Foseco Crucible (India) reports standalone net loss of Rs 1.40 crore in the March 2026 quarter

May 06,2026

Net loss of Foseco Crucible (India) reported to Rs 1.40 crore in the quarter ended March 2026 as against net profit of Rs 2.88 crore during the previous quarter ended March 2025. Sales declined 11.74% to Rs 37.35 crore in the quarter ended March 2026 as against Rs 42.32 crore during the previous quarter ended March 2025.

For the full year,net profit declined 32.03% to Rs 18.72 crore in the year ended March 2026 as against Rs 27.54 crore during the previous year ended March 2025. Sales declined 1.30% to Rs 171.92 crore in the year ended March 2026 as against Rs 174.19 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	37.35	42.32	-12	171.92	174.19	-1
OPM %	26.02	15.48	-	26.66	23.33	-
PBDT	15.47	8.04	92	56.74	48.37	17
PBT	12.64	5.42	133	45.13	39.32	15
NP	-1.40	2.88	PL	18.72	27.54	-32

79,310.01 2,008.61 ( 2.60%)

53,347.89 1,540.17 (2.97%)

7,717.41 127.49 (1.68%)

60,935.13 -1,253.50 (-2.02%)

10,852.07 213.64 (2.01%)

94.73 -0.07 (-0.07%)

105.99 -0.12 (-0.11%)

127.06 -0.04 (-0.03%)

0.60 0.00 (-0.31%)